OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/05/2025
Back to search
Official data from USPTO
VALINK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VALINK
ST13
US500000079397717Class
1, 5, 42
Filing
79397717
Registration
7757034
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
12/06/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
03/05/2024
Registration date
04/15/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/15/2025
Last transaction
12/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
SPILS,CAROL A
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Valink Therapeutics Inc.
Representatives
Matthew A. Homyk Blank Rome LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparations for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodiesother than for medical use; proteins for binding antibodiesother than for medical use; immunological antibodiesother than for medical use; chemical substances for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical substances for use in the production of drugs; chemicals for use in scientific researchother than medical or veterinary; chemicals for use in biotechnological product development
Class 5
Pharmaceuticalsmedical and veterinary preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer; antibodies for medical purposes
Class 42
Scientific and technological services and research and design relating thereto in the fields of pharmaceuticalbiomedicalchemical sciences; biotechnology research; biological research; clinical research in the field of radiology and chemotherapy; medical research; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology testing; scientific research relating to biotechnology; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemical research services of biochemistry drugs; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; scientific laboratory services; biochemical research laboratory services; medical research laboratory services; medical research laboratories; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/22/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/19/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/19/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/05/2025
FIMP
FINAL DISPOSITION PROCESSED
11/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/16/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/16/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/15/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/25/2025
PUBO
PUBLISHED FOR OPPOSITION
02/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/13/2024
RFNT
REFUSAL PROCESSED BY IB
11/17/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/29/2024
RFRR
REFUSAL PROCESSED BY MPU
10/15/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/10/2024
CNRT
NON-FINAL ACTION WRITTEN
10/09/2024
DOCK
ASSIGNED TO EXAMINER
09/18/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/21/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/20/2024
Continuous trademark protection
Get notified about every new filing that threatens VALINK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.